Ron Burch is currently an advisor at Allay Therapeutics. Prior to that, they were a Fellow at BioInnovate Ireland from August 2014 to May 2015. Ron has also worked as a Senior Development Engineer at Covidien from January 2013 to July 2014, and as a Research Associate at CooperVision from February 2012 to July 2012. Ron has also held positions as a Principal Scientist at Chrono Therapeutics from June 2015 to February 2019, and as an R&D Scientist at CV Ingenuity from July 2012 to January 2013. Ron began their career as a Scientist II at Conor Medsystems/Cordis, Johnson & Johnson in November 2007.
Ron Burch has a Master of Science in Bioinnovation from the University of Galway and a Bachelor of Science in Biochemical Engineering from the University of California, Davis.